| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Strides Pharma Science Limited (NSE: STAR)
STAR Technical Analysis
5
| As on 24th Apr 2024 STAR SHARE Price closed @ 881.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 566.00 & Strong Buy for SHORT-TERM with Stoploss of 798.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
STARSHARE Price
| Open | 902.40 | Change | Price | % |
| High | 902.40 | 1 Day | -11.65 | -1.30 |
| Low | 877.55 | 1 Week | 42.20 | 5.03 |
| Close | 881.70 | 1 Month | 104.55 | 13.45 |
| Volume | 235028 | 1 Year | 544.90 | 161.79 |
| 52 Week High 483.60 | 52 Week Low 266.40 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.10 | -9.03% |
| SAIL | 164.65 | 8.14% |
| YESBANK | 25.45 | -0.78% |
| TATASTEEL | 165.55 | 2.73% |
| IRFC | 149.00 | 0.85% |
| SOUTHBANK | 29.10 | 1.04% |
| MRPL | 248.70 | 10.75% |
| SUZLON | 41.80 | -0.12% |
| BEL | 236.50 | 0.92% |
| RAMASTEEL | 14.00 | 2.56% |
NSE INDIA Top Gainers Stocks
| ROML | 63.05 | 19.98% |
| COMPUSOFT | 35.20 | 19.93% |
| SHRADHA | 78.55 | 19.83% |
| STEELCITY | 102.95 | 19.78% |
| WEIZMANIND | 142.25 | 19.59% |
| TEMBO | 240.90 | 18.61% |
| CHENNPETRO | 1075.00 | 15.82% |
| YUKEN | 1180.65 | 13.81% |
| ORIENTCEM | 230.50 | 12.85% |
| AEGISCHEM | 604.50 | 12.41% |
NSE INDIA Top Losers Stocks
| STAR Daily Charts |
STAR Intraday Charts |
Whats New @ Bazaartrend |
STAR Free Analysis |
|
|
STAR Important Levels Intraday
| RESISTANCE | 929.59 |
| RESISTANCE | 914.23 |
| RESISTANCE | 904.74 |
| RESISTANCE | 895.24 |
| SUPPORT | 868.16 |
| SUPPORT | 858.66 |
| SUPPORT | 849.17 |
| SUPPORT | 833.81 |
STAR Target April 2024
| 4th UP Target | 1175.23 |
| 3rd UP Target | 1054.84 |
| 2nd UP Target | 980.43 |
| 1st UP Target | 906.02 |
| 1st DOWN Target | 693.68 |
| 2nd DOWN Target | 619.27 |
| 3rd DOWN Target | 544.86 |
| 4th DOWN Target | 424.47 |
STAR Weekly Target
| 4th UP Target | 950.78 |
| 3rd UP Target | 916.36 |
| 2nd UP Target | 895.08 |
| 1st UP Target | 873.81 |
| 1st DOWN Target | 813.09 |
| 2nd DOWN Target | 791.82 |
| 3rd DOWN Target | 770.54 |
| 4th DOWN Target | 736.12 |
STAR Target2024
| 4th UP Target | 1413.98 |
| 3rd UP Target | 1168.73 |
| 2nd UP Target | 1017.13 |
| 1st UP Target | 865.53 |
| 1st DOWN Target | 432.97 |
| 2nd DOWN Target | 281.37 |
| 3rd DOWN Target | 129.77 |
| 4th DOWN Target | -115.48 |
Strides Pharma Science Limited ( NSE INDIA Symbol : STAR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
STAR Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 27.89 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 425.32 | |
| 10 Day Avg Volume | Traded -24.68 % Less then 10 Day Average Volume | ||
STAR Other Details
| Segment | EQ | |
| Market Capital | 49301262336.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
STAR Address
 |
||
STAR Latest News
STAR Business Profile
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australasia, North America, Europe, Asia, India, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and oral liquids, as well as semi powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Clavicin, Combiart, Solcer, Melonax, Duotab, and Vitafer brands; and drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India. Address: Strides House, Bengaluru, India, 560076
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service